City

New York (1)

Condition

CLL Progression (2)

CLL/SLL (1)

Chronic Lymphocytic Leukemia (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Assiut University (1)

Weill Medical College of Cornell University (1)

Collaborator

TG Therapeutics, Inc. (1)

Intervention

emerald (1)

ublituximab (1)

umbralisib (1)

Study Documents

Intervention Type

device (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

CLL Progression

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Lymphocytic Leukemia, CLL Progression, CLL/SLL Trial in New York (Umbralisib, Ublituximab)

Recruiting

Chronic Lymphocytic Leukemia
+2 more

New York, New York

Weill Cornell Medicine

Mar 29, 2022

Platelet _lymphocyte and Neutrophil _monocyte in CLL

Not yet recruiting

CLL Progression

Emerald

(no location specified)

Mar 22, 2021